<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>2 Cerebrovascular | Vascular Surgery Exam Prep</title>
  <meta name="description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="2 Cerebrovascular | Vascular Surgery Exam Prep" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://adam-mdmph.github.io/VS-Board-Review/" />
  
  <meta property="og:description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  <meta name="github-repo" content="https://github.com/adam-mdmph/VS-Board-Review" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="2 Cerebrovascular | Vascular Surgery Exam Prep" />
  
  <meta name="twitter:description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  

<meta name="author" content="Editors: Adam Johnson, MD, MPH; Matt Smith, MD, PhD; and Audible Bleeding" />



  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="152x152" href="images/apple_icon.png" />
  
<link rel="prev" href="index.html"/>
<link rel="next" href="upper-extremity-and-thoracic-outlet.html"/>
<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">VS Board Review</a></li>

<li class="divider"></li>
<li><a href="index.html#about" id="toc-about"><span class="toc-section-number">1</span> About</a>
<ul>
<li><a href="index.html#usage" id="toc-usage"><span class="toc-section-number">1.1</span> Usage</a></li>
<li><a href="index.html#comments-questions-or-contributions" id="toc-comments-questions-or-contributions"><span class="toc-section-number">1.2</span> Comments, Questions or Contributions</a></li>
</ul></li>
<li><a href="cerebrovascular.html#cerebrovascular" id="toc-cerebrovascular"><span class="toc-section-number">2</span> Cerebrovascular</a>
<ul>
<li><a href="cerebrovascular.html#available-guidelines" id="toc-available-guidelines"><span class="toc-section-number">2.1</span> Available Guidelines</a></li>
<li><a href="cerebrovascular.html#presentation-and-diagnosis" id="toc-presentation-and-diagnosis"><span class="toc-section-number">2.2</span> Presentation and Diagnosis</a></li>
<li><a href="cerebrovascular.html#management" id="toc-management"><span class="toc-section-number">2.3</span> Management</a>
<ul>
<li><a href="cerebrovascular.html#optimal-medical-therapy" id="toc-optimal-medical-therapy"><span class="toc-section-number">2.3.1</span> Optimal medical therapy</a></li>
<li><a href="cerebrovascular.html#carotid-endarterectomy" id="toc-carotid-endarterectomy"><span class="toc-section-number">2.3.2</span> Carotid endarterectomy</a></li>
<li><a href="cerebrovascular.html#carotid-artery-stenting" id="toc-carotid-artery-stenting"><span class="toc-section-number">2.3.3</span> Carotid Artery Stenting</a></li>
<li><a href="cerebrovascular.html#management-of-uncommon-disease-presentations" id="toc-management-of-uncommon-disease-presentations"><span class="toc-section-number">2.3.4</span> Management of Uncommon Disease Presentations</a></li>
</ul></li>
<li><a href="cerebrovascular.html#prospective-trials---must-reads" id="toc-prospective-trials---must-reads"><span class="toc-section-number">2.4</span> Prospective Trials - MUST READS</a></li>
</ul></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#upper-extremity-and-thoracic-outlet" id="toc-upper-extremity-and-thoracic-outlet"><span class="toc-section-number">3</span> Upper Extremity and Thoracic Outlet</a>
<ul>
<li><a href="upper-extremity-and-thoracic-outlet.html#anatomy-exposure-of-vessels" id="toc-anatomy-exposure-of-vessels"><span class="toc-section-number">3.1</span> Anatomy/ Exposure of Vessels</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#epidemiology-etiology-and-diagnostic-evaluation" id="toc-epidemiology-etiology-and-diagnostic-evaluation"><span class="toc-section-number">3.2</span> Epidemiology, Etiology, and Diagnostic Evaluation</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#operationsprocedures" id="toc-operationsprocedures"><span class="toc-section-number">3.3</span> Operations/Procedures</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#vaso-occlusive-disease" id="toc-vaso-occlusive-disease"><span class="toc-section-number">3.4</span> Vaso-occlusive disease</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#vasospastic-disorders" id="toc-vasospastic-disorders"><span class="toc-section-number">3.5</span> Vasospastic Disorders</a>
<ul>
<li><a href="upper-extremity-and-thoracic-outlet.html#ergotism" id="toc-ergotism"><span class="toc-section-number">3.5.1</span> <strong>Ergotism</strong></a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#buergers-disease" id="toc-buergers-disease"><span class="toc-section-number">3.5.2</span> <strong>Buerger’s Disease</strong></a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#large-artery-vasculitis" id="toc-large-artery-vasculitis"><span class="toc-section-number">3.5.3</span> <strong>Large Artery Vasculitis</strong></a></li>
</ul></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#aneurysmal-disease" id="toc-aneurysmal-disease"><span class="toc-section-number">3.6</span> Aneurysmal Disease</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#occupational-vascular-disease" id="toc-occupational-vascular-disease"><span class="toc-section-number">3.7</span> Occupational Vascular Disease</a>
<ul>
<li><a href="upper-extremity-and-thoracic-outlet.html#hand-arm-vibration-syndrome" id="toc-hand-arm-vibration-syndrome"><span class="toc-section-number">3.7.1</span> Hand-Arm Vibration Syndrome </a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#hypothenar-hammer-syndrome" id="toc-hypothenar-hammer-syndrome"><span class="toc-section-number">3.7.2</span> Hypothenar hammer syndrome</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#environmental-exposures" id="toc-environmental-exposures"><span class="toc-section-number">3.7.3</span> Environmental Exposures</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#sports-medicine" id="toc-sports-medicine"><span class="toc-section-number">3.7.4</span> Sports Medicine</a></li>
</ul></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#vascular-trauma-upper-extremity" id="toc-vascular-trauma-upper-extremity"><span class="toc-section-number">3.8</span> Vascular Trauma-Upper Extremity</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#compression-syndromes" id="toc-compression-syndromes"><span class="toc-section-number">3.9</span> Compression Syndromes</a>
<ul>
<li><a href="upper-extremity-and-thoracic-outlet.html#quadrilateral-space-syndrome" id="toc-quadrilateral-space-syndrome"><span class="toc-section-number">3.9.1</span> Quadrilateral space syndrome</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#humeral-head-compression-of-axillary-artery" id="toc-humeral-head-compression-of-axillary-artery"><span class="toc-section-number">3.9.2</span> Humeral head compression of axillary artery</a></li>
</ul></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#thoracic-outlet-syndrome" id="toc-thoracic-outlet-syndrome"><span class="toc-section-number">3.10</span> Thoracic Outlet Syndrome</a>
<ul>
<li><a href="upper-extremity-and-thoracic-outlet.html#anatomy" id="toc-anatomy"><span class="toc-section-number">3.10.1</span> Anatomy</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#diagnosis-and-evaluation" id="toc-diagnosis-and-evaluation"><span class="toc-section-number">3.10.2</span> Diagnosis and Evaluation</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#rib-resection-approaches" id="toc-rib-resection-approaches"><span class="toc-section-number">3.10.3</span> Rib Resection approaches</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#vtos" id="toc-vtos"><span class="toc-section-number">3.10.4</span> vTOS</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#atos" id="toc-atos"><span class="toc-section-number">3.10.5</span> aTOS</a></li>
<li><a href="upper-extremity-and-thoracic-outlet.html#ntos" id="toc-ntos"><span class="toc-section-number">3.10.6</span> nTOS</a></li>
</ul></li>
</ul></li>
<li><a href="abdominal-aneurysms.html#abdominal-aneurysms" id="toc-abdominal-aneurysms"><span class="toc-section-number">4</span> Abdominal Aneurysms</a>
<ul>
<li><a href="abdominal-aneurysms.html#pathogenesis-presentation-and-risk-factors" id="toc-pathogenesis-presentation-and-risk-factors"><span class="toc-section-number">4.1</span> Pathogenesis, presentation and risk factors</a></li>
<li><a href="abdominal-aneurysms.html#evaluation-and-diagnosis" id="toc-evaluation-and-diagnosis"><span class="toc-section-number">4.2</span> Evaluation and Diagnosis</a>
<ul>
<li><a href="abdominal-aneurysms.html#imaging" id="toc-imaging"><span class="toc-section-number">4.2.1</span> Imaging</a></li>
</ul></li>
<li><a href="abdominal-aneurysms.html#management-1" id="toc-management-1"><span class="toc-section-number">4.3</span> Management</a>
<ul>
<li><a href="abdominal-aneurysms.html#evar" id="toc-evar"><span class="toc-section-number">4.3.1</span> EVAR</a></li>
<li><a href="abdominal-aneurysms.html#open-repair" id="toc-open-repair"><span class="toc-section-number">4.3.2</span> Open Repair</a></li>
<li><a href="abdominal-aneurysms.html#ruptured-aneurysms" id="toc-ruptured-aneurysms"><span class="toc-section-number">4.3.3</span> Ruptured Aneurysms</a></li>
</ul></li>
</ul></li>
<li><a href="iliacperipheral-aneurysms.html#iliacperipheral-aneurysms" id="toc-iliacperipheral-aneurysms"><span class="toc-section-number">5</span> Iliac/Peripheral Aneurysms</a></li>
<li><a href="lower-extremity-occlusive-disease.html#lower-extremity-occlusive-disease" id="toc-lower-extremity-occlusive-disease"><span class="toc-section-number">6</span> Lower Extremity Occlusive Disease</a>
<ul>
<li><a href="lower-extremity-occlusive-disease.html#pathophysiology" id="toc-pathophysiology"><span class="toc-section-number">6.1</span> Pathophysiology</a></li>
<li><a href="lower-extremity-occlusive-disease.html#intermittent-claudication" id="toc-intermittent-claudication"><span class="toc-section-number">6.2</span> Intermittent Claudication</a>
<ul>
<li><a href="lower-extremity-occlusive-disease.html#history-clinical-examination" id="toc-history-clinical-examination"><span class="toc-section-number">6.2.1</span> History / Clinical Examination</a></li>
<li><a href="lower-extremity-occlusive-disease.html#management-2" id="toc-management-2"><span class="toc-section-number">6.2.2</span> Management</a></li>
</ul></li>
<li><a href="lower-extremity-occlusive-disease.html#chronic-limb-threatening-ischemia" id="toc-chronic-limb-threatening-ischemia"><span class="toc-section-number">6.3</span> Chronic Limb Threatening Ischemia</a></li>
<li><a href="lower-extremity-occlusive-disease.html#acute-limb-ischemia" id="toc-acute-limb-ischemia"><span class="toc-section-number">6.4</span> Acute Limb Ischemia</a>
<ul>
<li><a href="lower-extremity-occlusive-disease.html#presentation-and-diangosis" id="toc-presentation-and-diangosis"><span class="toc-section-number">6.4.1</span> Presentation and Diangosis</a></li>
<li><a href="lower-extremity-occlusive-disease.html#management-3" id="toc-management-3"><span class="toc-section-number">6.4.2</span> Management</a></li>
<li><a href="lower-extremity-occlusive-disease.html#compartment-syndrome" id="toc-compartment-syndrome"><span class="toc-section-number">6.4.3</span> Compartment Syndrome</a></li>
</ul></li>
</ul></li>
<li><a href="mesenteric-disease.html#mesenteric-disease" id="toc-mesenteric-disease"><span class="toc-section-number">7</span> Mesenteric Disease</a>
<ul>
<li><a href="mesenteric-disease.html#acute-mesenteric-ischemia" id="toc-acute-mesenteric-ischemia"><span class="toc-section-number">7.1</span> Acute Mesenteric Ischemia</a>
<ul>
<li><a href="mesenteric-disease.html#presentation-and-diagnosis-1" id="toc-presentation-and-diagnosis-1"><span class="toc-section-number">7.1.1</span> Presentation and diagnosis</a></li>
<li><a href="mesenteric-disease.html#management-4" id="toc-management-4"><span class="toc-section-number">7.1.2</span> Management</a></li>
<li><a href="mesenteric-disease.html#rare-etiologies" id="toc-rare-etiologies"><span class="toc-section-number">7.1.3</span> Rare Etiologies</a></li>
</ul></li>
<li><a href="mesenteric-disease.html#chronic-mesenteric-ischemia" id="toc-chronic-mesenteric-ischemia"><span class="toc-section-number">7.2</span> Chronic Mesenteric Ischemia</a>
<ul>
<li><a href="mesenteric-disease.html#presentation-and-diagnosis-2" id="toc-presentation-and-diagnosis-2"><span class="toc-section-number">7.2.1</span> Presentation and Diagnosis</a></li>
<li><a href="mesenteric-disease.html#management-5" id="toc-management-5"><span class="toc-section-number">7.2.2</span> Management</a></li>
</ul></li>
<li><a href="mesenteric-disease.html#mesenteric-aneurysms" id="toc-mesenteric-aneurysms"><span class="toc-section-number">7.3</span> Mesenteric Aneurysms</a>
<ul>
<li><a href="mesenteric-disease.html#sma-aneurysm" id="toc-sma-aneurysm"><span class="toc-section-number">7.3.1</span> SMA Aneurysm</a></li>
<li><a href="mesenteric-disease.html#splenic-aneurysm" id="toc-splenic-aneurysm"><span class="toc-section-number">7.3.2</span> Splenic Aneurysm</a></li>
</ul></li>
<li><a href="mesenteric-disease.html#median-arcuate-ligament-syndrome-mals" id="toc-median-arcuate-ligament-syndrome-mals"><span class="toc-section-number">7.4</span> Median Arcuate Ligament Syndrome (MALS)</a></li>
<li><a href="mesenteric-disease.html#sma-syndrome" id="toc-sma-syndrome"><span class="toc-section-number">7.5</span> SMA Syndrome</a></li>
<li><a href="mesenteric-disease.html#uterine-fibroids" id="toc-uterine-fibroids"><span class="toc-section-number">7.6</span> Uterine Fibroids</a></li>
</ul></li>
<li><a href="renal.html#renal" id="toc-renal"><span class="toc-section-number">8</span> Renal</a>
<ul>
<li><a href="renal.html#pathophysiology-1" id="toc-pathophysiology-1"><span class="toc-section-number">8.1</span> Pathophysiology</a></li>
<li><a href="renal.html#medical-management-and-evaluation" id="toc-medical-management-and-evaluation"><span class="toc-section-number">8.2</span> Medical Management and Evaluation</a></li>
<li><a href="renal.html#operative-managment" id="toc-operative-managment"><span class="toc-section-number">8.3</span> Operative Managment</a>
<ul>
<li><a href="renal.html#endovascular-therapy" id="toc-endovascular-therapy"><span class="toc-section-number">8.3.1</span> Endovascular Therapy</a></li>
<li><a href="renal.html#open-surgery" id="toc-open-surgery"><span class="toc-section-number">8.3.2</span> Open Surgery</a></li>
</ul></li>
<li><a href="renal.html#fibromuscular-dysplasia-fmd" id="toc-fibromuscular-dysplasia-fmd"><span class="toc-section-number">8.4</span> Fibromuscular Dysplasia (FMD)</a></li>
<li><a href="renal.html#renal-artery-aneurysms" id="toc-renal-artery-aneurysms"><span class="toc-section-number">8.5</span> Renal Artery Aneurysms</a>
<ul>
<li><a href="renal.html#demographics-2" id="toc-demographics-2"><span class="toc-section-number">8.5.1</span> Demographics</a></li>
<li><a href="renal.html#anatomy-1" id="toc-anatomy-1"><span class="toc-section-number">8.5.2</span> Anatomy</a></li>
<li><a href="renal.html#presentation-2" id="toc-presentation-2"><span class="toc-section-number">8.5.3</span> Presentation</a></li>
<li><a href="renal.html#management-6" id="toc-management-6"><span class="toc-section-number">8.5.4</span> Management</a></li>
</ul></li>
<li><a href="renal.html#renal-artery-dissection" id="toc-renal-artery-dissection"><span class="toc-section-number">8.6</span> Renal Artery Dissection</a></li>
<li><a href="renal.html#renal-vein-thrombosis" id="toc-renal-vein-thrombosis"><span class="toc-section-number">8.7</span> Renal Vein Thrombosis</a>
<ul>
<li><a href="renal.html#diagnosis-1" id="toc-diagnosis-1"><span class="toc-section-number">8.7.1</span> Diagnosis</a></li>
<li><a href="renal.html#management-7" id="toc-management-7"><span class="toc-section-number">8.7.2</span> Management</a></li>
</ul></li>
<li><a href="renal.html#renal-arteriovenous-fistula" id="toc-renal-arteriovenous-fistula"><span class="toc-section-number">8.8</span> Renal Arteriovenous Fistula</a></li>
</ul></li>
<li><a href="thoracic-aorta.html#thoracic-aorta" id="toc-thoracic-aorta"><span class="toc-section-number">9</span> Thoracic Aorta</a>
<ul>
<li><a href="thoracic-aorta.html#aortic-dissection" id="toc-aortic-dissection"><span class="toc-section-number">9.1</span> Aortic Dissection</a></li>
<li><a href="thoracic-aorta.html#thoracoabdominal-aneurysms-taaa" id="toc-thoracoabdominal-aneurysms-taaa"><span class="toc-section-number">9.2</span> Thoracoabdominal Aneurysms (TAAA)</a></li>
</ul></li>
<li><a href="studio-sound-version.html#studio-sound-version" id="toc-studio-sound-version"><span class="toc-section-number">10</span> Studio sound version</a>
<ul>
<li><a href="studio-sound-version.html#aortopathies" id="toc-aortopathies"><span class="toc-section-number">10.1</span> Aortopathies</a>
<ul>
<li><a href="studio-sound-version.html#links" id="toc-links"><span class="toc-section-number">10.1.1</span> LINKS:</a></li>
</ul></li>
</ul></li>
<li><a href="venous-disease.html#venous-disease" id="toc-venous-disease"><span class="toc-section-number">11</span> Venous Disease</a></li>
<li><a href="rouleaux-club---venous-review.html#rouleaux-club---venous-review" id="toc-rouleaux-club---venous-review"><span class="toc-section-number">12</span> Rouleaux Club - Venous Review</a></li>
<li><a href="vascular-trauma.html#vascular-trauma" id="toc-vascular-trauma"><span class="toc-section-number">13</span> Vascular Trauma</a>
<ul>
<li><a href="vascular-trauma.html#peripheral" id="toc-peripheral"><span class="toc-section-number">13.1</span> Peripheral</a></li>
<li><a href="vascular-trauma.html#abdominal-arterial" id="toc-abdominal-arterial"><span class="toc-section-number">13.2</span> Abdominal Arterial</a></li>
<li><a href="vascular-trauma.html#abdominal-venous" id="toc-abdominal-venous"><span class="toc-section-number">13.3</span> Abdominal Venous</a></li>
<li><a href="vascular-trauma.html#cerebrovascular-trauma" id="toc-cerebrovascular-trauma"><span class="toc-section-number">13.4</span> Cerebrovascular Trauma</a></li>
<li><a href="vascular-trauma.html#endovascular-approaches" id="toc-endovascular-approaches"><span class="toc-section-number">13.5</span> Endovascular Approaches</a></li>
</ul></li>
<li><a href="angioaccess.html#angioaccess" id="toc-angioaccess"><span class="toc-section-number">14</span> Angioaccess</a></li>
<li><a href="vascular-lab.html#vascular-lab" id="toc-vascular-lab"><span class="toc-section-number">15</span> Vascular Lab</a>
<ul>
<li><a href="vascular-lab.html#overview" id="toc-overview"><span class="toc-section-number">15.1</span> <strong>Overview</strong></a>
<ul>
<li><a href="vascular-lab.html#waveforms" id="toc-waveforms"><span class="toc-section-number">15.1.1</span> Waveforms</a></li>
</ul></li>
<li><a href="vascular-lab.html#extracranial" id="toc-extracranial"><span class="toc-section-number">15.2</span> Extracranial</a></li>
<li><a href="vascular-lab.html#intracranial" id="toc-intracranial"><span class="toc-section-number">15.3</span> Intracranial</a></li>
<li><a href="vascular-lab.html#upper-extremity" id="toc-upper-extremity"><span class="toc-section-number">15.4</span> Upper Extremity</a>
<ul>
<li><a href="vascular-lab.html#hemodialysis-access" id="toc-hemodialysis-access"><span class="toc-section-number">15.4.1</span> Hemodialysis Access</a></li>
</ul></li>
<li><a href="vascular-lab.html#lower-extremity" id="toc-lower-extremity"><span class="toc-section-number">15.5</span> Lower Extremity</a>
<ul>
<li><a href="vascular-lab.html#pathologies" id="toc-pathologies"><span class="toc-section-number">15.5.1</span> Pathologies</a></li>
</ul></li>
<li><a href="vascular-lab.html#abdominal" id="toc-abdominal"><span class="toc-section-number">15.6</span> Abdominal</a>
<ul>
<li><a href="vascular-lab.html#aorta" id="toc-aorta"><span class="toc-section-number">15.6.1</span> Aorta</a></li>
<li><a href="vascular-lab.html#mesenteric-vasculature" id="toc-mesenteric-vasculature"><span class="toc-section-number">15.6.2</span> Mesenteric Vasculature</a></li>
</ul></li>
<li><a href="vascular-lab.html#venous" id="toc-venous"><span class="toc-section-number">15.7</span> Venous</a></li>
<li><a href="vascular-lab.html#artifacts" id="toc-artifacts"><span class="toc-section-number">15.8</span> Artifacts</a></li>
</ul></li>
<li><a href="endovascular.html#endovascular" id="toc-endovascular"><span class="toc-section-number">16</span> Endovascular</a>
<ul>
<li><a href="endovascular.html#vascular-access" id="toc-vascular-access"><span class="toc-section-number">16.1</span> Vascular Access</a></li>
</ul></li>
<li><a href="references.html#references" id="toc-references">References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Vascular Surgery Exam Prep</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="cerebrovascular" class="section level1" number="2">
<h1><span class="header-section-number">2</span> Cerebrovascular</h1>
<p><strong>07 Jan 2019:</strong> <em>Adam Johnson, MD, MPH; Nicole Rich, MD, MPH; Kevin
Kniery, MD, MPH</em></p>
<p><audio controls> <source src='https://traffic.libsyn.com/audiblebleeding/E7_-_Carotid_VSITE.mp3' type='audio/mpeg'> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio></p>
<div id="available-guidelines" class="section level2" number="2.1">
<h2><span class="header-section-number">2.1</span> Available Guidelines</h2>
<p><a href="https://www.jvascsurg.org/article/S0741-5214(21)00893-4/fulltext">Society for Vascular Surgery clinical practice guidelines for
management of extracranial cerebrovascular
disease</a><span class="citation"><sup>[<a href="#ref-aburahmaSocietyVascularSurgery2022" role="doc-biblioref">1</a>]</sup></span></p>
</div>
<div id="presentation-and-diagnosis" class="section level2" number="2.2">
<h2><span class="header-section-number">2.2</span> Presentation and Diagnosis</h2>
<ol style="list-style-type: decimal">
<li><p><strong>What is the definition of crescendo TIAs?</strong></p>
<p>Frequent repetitive neurological attacks without complete resolution
of the deficit between the episodes, usually over a 24 hour period.
The result of which is the same neurological deficit. If the patient
exhibits progressive deterioration in neurological function between
TIA episodes this is classified as a stroke in evolution not a
crescendo TIA. <!--# Add Reference --></p></li>
<li><p><strong>Who needs to be screened for carotid disease?</strong></p>
<p>Not everyone should be screened for carotid disease, however, as
only 15% of patients who have a stroke experience a warning TIA
prior to their event, there is merit in screening high risk
patients. The purpose of carotid bifurcation imaging is to detect
“stroke-prone” carotid bifurcation plaque and identify a high-risk
patient likely to benefit from therapy designed to reduce stroke
risk.</p>
<p>Traditionally, the clinical sign associated with carotid stenosis is
the prescence of a neck bruit on auscultation. Focal ipsilateral
carotid bruits in symptomatic patients has a sensitivity of 63% and
a specificity of 61% for high-grade carotid stenosis (range,
70%-99%). As these figures suggest the absence of carotid bruit does
not absolutely exclude the presence of a significant carotid
bifurcation lesion, therefore additional criteria are used to
determine which patients would benefit from screening:</p>
<ul>
<li><p>Evidence of clinically significant peripheral vascular disease
regardless of age</p></li>
<li><p>Patients aged &gt;65 years with a history of one or more of the
following atherosclerotic risk factors:</p>
<ul>
<li><p>CAD</p></li>
<li><p>Smoking</p></li>
<li><p>Hypercholesterolemia</p></li>
</ul></li>
<li><p>In general, the more risk factors present, the higher the yield
of screening for the patient.</p></li>
<li><p>The benefit of prophylactic treatment of high grade stenosis is
estimated at a 1-2% stroke reduction risk per year.<span class="citation"><sup>[<a href="#ref-naylorWhyManagementAsymptomatic2015" role="doc-biblioref">2</a>]</sup></span></p></li>
<li><p>Keep in mind that intervention (CEA/CAS) has only demonstrated a
benefit in asymptomatic patient with life expectancy greater
than 3 years.<span class="citation"><sup>[<a href="#ref-bulbuliaAsymptomaticCarotidSurgery2017" role="doc-biblioref">3</a>–<a href="#ref-rosenfieldRandomizedTrialStent2016" role="doc-biblioref">5</a>]</sup></span></p></li>
</ul></li>
<li><p><strong>Ultrasound Imaging</strong></p>
<ul>
<li><p>US is considered the best, least invasive, and cost effective
method for detecting carotid stenosis on screening.</p></li>
<li><p>50-69% stenosis of ICA - US has a low sensitivity for 50-69%
stenosis. A negative ultrasound in symptomatic patients
necessitates additional imaging. Typically on scanning if 50-69%
ICA stenosis is present:</p>
<ul>
<li>PSV 125-229 cm/sec</li>
<li>EDV 40-100</li>
<li>Internal/Common Carotid PSV Ratio 2-4</li>
</ul></li>
<li><p>70-99% stenosis of ICA- Typically on scanning:</p>
<ul>
<li><p>PSV &gt;/= 230 cm/sec</p></li>
<li><p>EDV &gt;100 (EDV &gt; 140 cm/sec most sensitive for stenosis &gt;80%)</p></li>
<li><p>Internal/Common Carotid PSV Ratio &gt; 4</p></li>
</ul></li>
<li><p>Velocity-based estimation of carotid artery stenosis may need to
be adjusted in certain circumstances:</p>
<ul>
<li><p>Higher velocities in women than in men.</p></li>
<li><p>Higher velocities in the presence of contralateral carotid
artery occlusion.</p></li>
</ul></li>
<li><p>High carotid bifurcation, severe arterial tortuosity, extensive
vascular calcification, and obesity may also reduce the accuracy
of US imaging.</p></li>
</ul></li>
<li><p><strong>Other Imaging Modalities</strong></p>
<ul>
<li><p>CTA</p>
<ul>
<li><p>Pro - fast, sub-millimeter spatial resolution, visualize
surrounding structures.</p></li>
<li><p>Con - cost, contrast exposure.</p></li>
</ul></li>
<li><p>MRA</p>
<ul>
<li><p>Pro - no contrast administered; can analyze plaque
morphology.</p></li>
<li><p>Con - Does not visualize calcium in plaque; overestimates
the degree of stenosis (False positive for 50-69% to be read
as &gt;70%).</p></li>
</ul></li>
<li><p>Catheter-based digital subtraction imaging (DSA)</p>
<ul>
<li><p>Still considered by many the gold-standard imaging modality.</p></li>
<li><p>Reserved for individuals with conflicting less-invasive
imaging or those considered for CAS.</p></li>
<li><p>Con - cost, contrast, and risk of stroke.</p></li>
</ul></li>
</ul></li>
</ol>
</div>
<div id="management" class="section level2" number="2.3">
<h2><span class="header-section-number">2.3</span> Management</h2>
<div id="optimal-medical-therapy" class="section level3" number="2.3.1">
<h3><span class="header-section-number">2.3.1</span> Optimal medical therapy</h3>
<p>First line management for asymptomatic patients with carotid stenosis is
medical optimisation of risk factors.</p>
<p><strong>Hypertension</strong></p>
<ul>
<li><p>Blood pressure reduction, with a target of &lt;140/90 mmHg through
lifestyle interventions and anti-hypertensive treatment is
recommended in individuals who have hypertension with asymptomatic
carotid atherosclerosis or those with TIA or stroke after the
hyper-acute period.</p></li>
<li><p>Each 10-mm Hg reduction in blood pressure among hypertensive
patients decreases the risk of stroke by 33%.
<!--# Add Reference --></p></li>
</ul>
<p><strong>Diabetes</strong></p>
<ul>
<li>In diabetic patients glycaemic control to nearly normoglycemic
levels (target hemoglobin A1C &lt;7%) is recommended to reduce
microvascular complications and, with a smaller evidence base,
macrovascular complications other than stroke.
<!--# Add Reference --></li>
</ul>
<p><strong>Hypercholesterolaemia</strong></p>
<ul>
<li><p>Risk of stroke decreased by &gt;15% for every 10% reduction in serum
LDL in patients with known coronary or other atherosclerosis.
<!--# Add Reference --></p></li>
<li><p>Statin agents are recommended targetting LDL of 100 mg/dL, for those
with coronary heart disease or symptomatic atherosclerotic disease,
and LDL of 70 mg/dL for very high-risk persons with multiple risk
factors.</p></li>
<li><p>High dose statin therapy in patients with TIA/stroke reduce future
rates of stroke or cardiovascular events but not overall mortality
at 5 years.<span class="citation"><sup>[<a href="#ref-karamHighDoseAtorvastatinStroke2008" role="doc-biblioref">6</a>]</sup></span></p></li>
</ul>
<p><strong>Smoking Cessation</strong> - Encouraging smoking cessation is paramount for
these patients. Physician counseling is an important and effective
intervention that reduces smoking in patients by 10% to 20%. (REF)</p>
<p><strong>Antithrombotic therapy</strong> - Aspirin is the only antiplatelet agent that
has demonstrated improved benefit in asymptomatic patients with carotid
atherosclerosis. <!--# Add Reference --></p>
</div>
<div id="carotid-endarterectomy" class="section level3" number="2.3.2">
<h3><span class="header-section-number">2.3.2</span> Carotid endarterectomy</h3>
<p><strong>Indications for Surgical Intervention</strong></p>
<ul>
<li><p>Recommendations on when to operate after a TIA/stroke.</p>
<ul>
<li><p>Acute stroke with a fixed neurologic deficit of &gt;6h duration -
When the patient is medically stable, intervention in 14 days or
less after stroke is preferable.<span class="citation"><sup>[<a href="#ref-rothwellEndarterectomySymptomaticCarotid2004" role="doc-biblioref">7</a>,<a href="#ref-meershoekTimingCarotidIntervention2018" role="doc-biblioref">8</a>]</sup></span></p></li>
<li><p>Consider urgent intervention in a medically stable patient with
mild-moderate neurologic deficit, if there is a significant area
of ischemic penumbra at risk for progression on imaging that is
contributing to the patient’s presentation.</p></li>
<li><p>Stroke in evolution (fluctuating / evolving neurological
deficit) or crescendo TIA (repetitive transient ischemia with
improvement between events) - If the patient’s neurological
status is not stabilized by medical intervention then an urgent
CEA should be considered.</p></li>
<li><p>In this clinical context CEA is preferred to CAS based on an
increased embolic potential of carotid lesions.<span class="citation"><sup>[<a href="#ref-rantnerEarlyEndarterectomyCarries2017" role="doc-biblioref">9</a>]</sup></span></p></li>
<li><p>Management of acute stroke<span class="citation"><sup>[<a href="#ref-powers2018GuidelinesEarly2018" role="doc-biblioref">10</a>]</sup></span></p>
<ul>
<li><p>&lt;4.5hrs from onset of symptoms - medical thrombolysis with
tPA unless contraindicated.</p>
<ul>
<li><p>Patient age &gt;80 and diabetes are contraindications to
tPA administration after 3hrs.</p></li>
<li><p>Other contraindications include - hypertension,
intracranial hemorrhage, recent stroke or cranial
trauma, spine/brain surgery within 3 months, GI bleed
within 21 days.</p></li>
</ul></li>
<li><p>&lt;6hr from onset of symptoms - catheter directed therapy</p></li>
</ul></li>
</ul></li>
<li><p>What is the only emergent indication for CEA?</p>
<ul>
<li>Crescendo TIAs or a stroke in evolution with a surgically
correctable lesion identified on imaging.</li>
</ul></li>
</ul>
<p><strong>CEA Intraoperative Techniques</strong></p>
<ul>
<li><p>General concepts</p>
<ul>
<li>Patch angioplasty or eversion endarterectomy are recommended
over primary arterial closure to reduce early and late
complications of CEA (GRADE 1, Level of Evidence A). # Add
Reference</li>
</ul></li>
<li><p>Neuromonitoring/Shunting options during a carotid endarterectomy</p>
<ul>
<li><p>Procedure performed under local/regional anesthesia with direct
neurological monitoring - the benefit being that the patient is
awake and moving to command throughout the case. Improved
neuromonitoring, however, has not been shown to reduce MI
(myocardial infarction?) rate with CEA. <!--# Add Reference --></p></li>
<li><p>Determining shunt use using stump pressure- Clamp the inflow and
place a butterfly attached to a-line tubing into the internal
carotid atery. If the stump pressure is &gt; 40 mmHg the surgeon
can chose to proceed without shunt placement, if &lt; 40mmHg then
a shunt should be placed prior to proceeding.
<!--# Add Reference --></p></li>
<li><p>EEG Neuromonitoring - EEG tech places neuromonitoring, monitored
by the technician and neurologist remotely intraoperatively.
Generally the surgeon should clamp the ICA for 3 minutes before
proceeding, if the patient develops neurological deficit/EEG
abnormalities then unclamp, await normalization of EEG, then
proceed.</p></li>
<li><p>Non-selective shunting - the surgeon uses a shunt for all CEAs
as standard practice, this is often done for all CEAs performed
under general anaesthesia.</p></li>
</ul></li>
<li><p>Techniques to reach high internal carotid lesions?</p>
<ul>
<li><p>A good knowledge of the available imaging while preparing for
the procedure is essential when considering the level of the
carotid bifurcation.</p></li>
<li><p>Nasotracheal intubation will allow for jaw closure and neck
extension to facilitate exposure of higher lesions.</p></li>
<li><p>Division of the posterior belly of the digastric muscle can be
performed to improve exposure of a high bifurcation. Care should
be taken to identify and preserve the glossopharyngeal nerve.</p></li>
<li><p>Styloidectomy.</p></li>
<li><p>ENT surgeon assisted mandible subluxation with assistance if
previous techniques fail.</p></li>
</ul></li>
<li><p>What is the best technique for a patient with an anatomically kinked
internal carotid artery?</p>
<ul>
<li><p>Eversion carotid endarterectomy (only indication for selection
for this technique over patch endarterectomy), transection
allows for reduction of redundancy at re-anastamosis.</p></li>
<li><p>Otherwise, no advantage has been shown between eversion or
patch, both can be shunted.</p></li>
</ul></li>
<li><p>Nerve Injuries – where you would encounter these and, if injured,
what deficit would be seen?</p>
<ul>
<li><p>Hypoglossal: Most commonly injured. Usually passes above the
bifurcation of the carotid artery. If injured the tongue will
deviate toward the side of injury on protrusion.</p></li>
<li><p>Glossopharyngeal: Commonly injured during high dissections.
Found under the posterior digastric muscle. Injury can be
devastating for patients resulting in difficulty swallowing and
high aspiration risk.</p></li>
<li><p>Vagus: Usually found adjacent and lateral to the common carotid.
Injury can occur with carotid clamping. Patients develop
hoarseness due to innervation of the laryngeal muscles from the
recurrent laryngeal nerve which is a branch of the vagus.</p></li>
<li><p>Marginal Mandibular: Branch of the facial nerve. Runs inferiorly
to the angle of the mandible. Commonly a retraction injury
during high dissections leading to the corner of the ipsilateral
lip drooping, can be confused with a significant neurological
deficit following the case.</p></li>
</ul></li>
</ul>
<p><strong>Postoperative Complications</strong></p>
<ul>
<li><p>What to do if the patient develops neuro deficits following carotid
endarterectomy: Two main concerns- an intimal flap causing
thrombosis or an embolic event resulting in a stroke. Perform a
thorough neurological exam to confirm in operated corotid territory.</p>
<ul>
<li><p>If in OR – perform duplex, if normal open wound and perform a
cerebral angiogram.</p></li>
<li><p>If in Recovery or on the floor – many would consider CTA first
line vs duplex to look for thrombosis.</p></li>
</ul></li>
<li><p>Risk factors and how to manage hyperperfusion syndrome?</p>
<ul>
<li><p>Defined as an ipsilateral headache, hypertension, seizures, and
focal neurological deficits likely in distribution of the
carotid. Can present 2-3 days post surgery.</p></li>
<li><p>Patients with uncontrolled hypertension are at risk for
hyperperfusion syndrome, clinical practice guidelines from SVS
recommend strict BP control following CEA, with target pressure
being less than 140/80mmHg.</p></li>
</ul></li>
<li><p>High risk groups</p>
<ul>
<li>ESRD patients have higher rates of perioperative stroke, but
also have higher rates of stroke if not revascularized.<span class="citation"><sup>[<a href="#ref-klarinPerioperativeLongtermImpact2016" role="doc-biblioref">11</a>]</sup></span></li>
</ul></li>
</ul>
<p><strong>Long term complications and follow up</strong></p>
<ul>
<li><p>Recommend f/u US duplex of bilateral carotids at &lt;/=30 days. &gt;/=
50% stenosis further imaging is indicated.</p></li>
<li><p>Contralateral stenosis:</p>
<ul>
<li><p>The risk of progression for moderate stenosis at the initial
surveillance to severe stenosis in the contralateral artery can
be as high as 5 times.</p></li>
<li><p>Requires post-operative surveillance.</p></li>
</ul></li>
</ul>
</div>
<div id="carotid-artery-stenting" class="section level3" number="2.3.3">
<h3><span class="header-section-number">2.3.3</span> Carotid Artery Stenting</h3>
<ul>
<li><p>In patients aged &gt;70 the risk of intra- or post procedure stroke was
the highest, if undergoing CAS, presumably due to calcified disease
in the arch.</p>
<ul>
<li><p>Lesion-specific characteristics are thought to increase the risk
of cerebral vascular events after CAS and include a “soft”
lipid-rich plaque identified on noninvasive imaging, extensive
(15 mm or more) disease, a pre-occlusive lesion, and
circumferential heavy calcification.</p></li>
<li><p>This risk can be reduced, but not eliminated, by using
flow-reversal embolic protection rather than distal filter
protection.</p></li>
</ul></li>
<li><p>Limited data is available on CAS in asymptomatic patients -
currently is not supported by guidelines or considered reimbursable.</p></li>
<li><p>Consider CAS in symptomatic patients with &gt;50% stenosis who are poor
candidates for CEA due to severe uncorrectable medical comorbidities
and/or anatomic considerations:</p>
<ul>
<li><p>Ipsilateral neck dissection or XRT - equivalent periprocedural
stroke rate to CEA, but increased later stroke rate. CEA higher
rates of cranial nerve damage (9%).<span class="citation"><sup>[<a href="#ref-giannopoulosRevascularizationRadiationinducedCarotid2018" role="doc-biblioref">12</a>]</sup></span></p></li>
<li><p>Contralateral vocal cord paralysis.</p></li>
<li><p>Lesions that extend proximally to the clavicle or distal to C2.</p></li>
</ul></li>
<li><p>Transfemoral Approach vs Transcarotid approach</p>
<ul>
<li>ROADSTER Trial - single arm study with flow reversal for
cerebral protection. Suggested lower rates of post-op stroke in
patients undergoing TCAR.</li>
</ul></li>
<li><p>Post-CAS follow up - Dual-platelet therapy should be continued for 1
month after the procedure, and aspirin should be continued
indefinitely.</p>
<ul>
<li>In stent restenosis (&gt;50%) - repeat angioplasty or stent have
low incidence of periprocedural stroke but failed to improve
long term stroke/death/MI or patency rates.<span class="citation"><sup>[<a href="#ref-chungPercutaneousInterventionCarotid2016a" role="doc-biblioref">13</a>]</sup></span></li>
</ul></li>
</ul>
</div>
<div id="management-of-uncommon-disease-presentations" class="section level3" number="2.3.4">
<h3><span class="header-section-number">2.3.4</span> Management of Uncommon Disease Presentations</h3>
<ul>
<li><p>Occluded Carotid: What is the management of an occluded carotid?</p>
<ul>
<li>Leave it alone.</li>
</ul></li>
<li><p>What if an occluded carotid on imaging is still causing TIAs?</p>
<ul>
<li><p>External carotid endarterectomy and ligation of the internal
carotid.</p></li>
<li><p>The addition of oral anticoagulation is likely to reduce the
rate of recurrent stroke.</p></li>
</ul></li>
<li><p>What if the patient has severe vertebrobasilar insufficiency and
carotid artery disease?</p>
<ul>
<li>Should undergo carotid revascularization first to improve flow.
Then reassess for vertebrobasilar insufficency.</li>
<li>Vertebrobasilar insufficiency characterized by dizziness,
ataxia, nausea, vertigo and bilateral weakness.<span class="citation"><sup>[<a href="#ref-limanetoPathophysiologyDiagnosisVertebrobasilar2017" role="doc-biblioref">14</a>]</sup></span></li>
</ul></li>
<li><p>What about tandem lesions in the carotid in a symptomatic patient,
carotid bulb and carotid siphon lesion (high ICA)? How should you
treat this?</p>
<ul>
<li>Treat carotid bulb first, likely to be the embolic source.</li>
</ul></li>
<li><p>Carotid artery dissection</p>
<ul>
<li><p>Patients with carotid dissection should be initially treated
with antithrombotic therapy (antiplatelet agents or
anticoagulation) (GRADE 1, Level of Evidence C).</p></li>
<li><p>Indications for endovascular treatment of carotid artery
dissection<span class="citation"><sup>[<a href="#ref-cohenSinglecenterExperienceEndovascular2012" role="doc-biblioref">15</a>–<a href="#ref-phamEndovascularStentingExtracranial2011" role="doc-biblioref">17</a>]</sup></span></p>
<ul>
<li><p>Ongoing symptoms on best medical therapy</p></li>
<li><p>Contraindication to antithrombotics</p></li>
<li><p>Pseudoaneurysm</p></li>
</ul></li>
</ul></li>
<li><p>Simultaneous coronary and carotid disease</p>
<ul>
<li><p>Patients with symptomatic carotid stenosis will benefit from CEA
before or concomitant with CABG. The timing of the intervention
depends on the clinical presentation and institutional
experience (GRADE 1, Level of Evidence B).</p></li>
<li><p>Patients with severe bilateral asymptomatic carotid stenosis,
including stenosis and contralateral occlusion, should be
considered for CEA before or concomitant with CABG (GRADE 2,
Level of Evidence B).</p></li>
<li><p>Patients undergoing simultaneous CEA/CABG demonstrate highest
mortality.<span class="citation"><sup>[<a href="#ref-naylorSystematicReviewOutcomes2003" role="doc-biblioref">18</a>]</sup></span></p></li>
</ul></li>
</ul>
</div>
</div>
<div id="prospective-trials---must-reads" class="section level2" number="2.4">
<h2><span class="header-section-number">2.4</span> Prospective Trials - MUST READS</h2>
<ol style="list-style-type: decimal">
<li><p>Asymptomatic Carotid Atherosclerosis Study (ACAS)</p>
<ul>
<li><p>Compared medical management with CEA in asymptomatic patients
with &gt; 60% stenosis.</p></li>
<li><p>5-year stroke and death rate was 5.1% vs 11%.</p></li>
<li><p>In women, the benefit of CEA was not as certain as 5y stroke and
death rates were 7.3% vs. 8.7%.</p></li>
<li><p>This trial was conducted pre-statin and clopidogrel era.</p></li>
</ul></li>
<li><p>North American Symptomatic Carotid Endarterectomy Trial (NASCET)<span class="citation"><sup>[<a href="#ref-northamericansymptomaticcarotidendarterectomytrialcollaboratorsBeneficialEffectCarotid1991" role="doc-biblioref">19</a>]</sup></span></p>
<ul>
<li><p>Compared medical management vs CEA for symptomatic patients with
moderate (50-69%) and severe stenosis (&gt;70%)</p></li>
<li><p>Only moderate impact for patients with moderate stenosis
(50-69%)</p></li>
<li><p>Symptomatic patients with &gt;70 % stenosis benefited from CEA, at
18 months 7% major stroke in surgical arm, and a 24% stroke rate
in medical arm. 29% reduction in 5-year risk of stroke or death.</p>
<ul>
<li>Patients with severe &gt;70% stenosis had such a dramatic
effect the trial was stopped early for this subset and all
referred for endarterectomy.</li>
</ul></li>
<li><p>No benefit is shown in symptomatic patients with &lt; 50% stenosis</p></li>
<li><p>European studies have shown similar results</p>
<ul>
<li><p>ACST = ACAS</p></li>
<li><p>ECST = NASCET.</p></li>
</ul></li>
<li><p><strong>Take a listen!</strong> <a href="https://www.audiblebleeding.com/2021/09/29/landmark-papers-nascet/">Click hear to listen to Dr. William Jordan
discuss this landmark
paper!</a></p></li>
</ul></li>
<li><p>Carotid Revascularization Endarterectomy versus Stenting Trial
(CREST).</p>
<ul>
<li><p>Compared CEA vs. CAS in both symptomatic and asymptomatic
patients.</p></li>
<li><p>Composite endpoint of 30-day stroke, MI, death equivalent
between CEA and CAS.</p></li>
<li><p>CAS had a significantly higher incidence of stroke and death
than CEA and CEA higher incidence of MI.</p>
<ul>
<li>Follow up at 10 years demonstrated no difference in
composite stroke/MI/death but increased rate of stroke/death
in stented patients likely attributable to increased
periprocedural stroke.<span class="citation"><sup>[<a href="#ref-brottLongTermResultsStenting2016b" role="doc-biblioref">20</a>]</sup></span></li>
</ul></li>
<li><p>Subanalyses identified that older patients (&gt;70y) had better
outcomes after CEA than CAS, the QOL impact of stroke was more
significant than that of MI, and anatomic characteristics of
carotid lesions (longer, sequential, remote) were predictive of
increased stroke and death after CAS.</p></li>
<li><p>Unfortunately, this study provides a benchmark to strive for,
but no other large trials have achieved these results.</p></li>
</ul></li>
<li><p>ROADSTER</p>
<ul>
<li><p>Single arm feasibility trial of transcarotid carotid stenting.</p></li>
<li><p>The results of the ROADSTER trial demonstrate that the use of
the ENROUTE Transcarotid NPS is safe and effective at preventing
stroke during CAS. The overall stroke rate of 1.4% is the lowest
reported to date for any prospective, multicenter clinical trial
of CAS.</p></li>
</ul></li>
<li><p>Trials to look out for in the next few years:</p>
<ul>
<li><p>CREST-2 - a multicenter, randomized controlled trial underway
evaluating revascularization against modern intensive medical
management.</p></li>
<li><p>ACT-1 and ACST-2- the role of intervention in asymptomatic
patients, designed to compare the early and long-term results of
CEA vs CAS and best medical management.</p></li>
<li><p>ROADSTER-2 - TCAR.</p></li>
</ul></li>
</ol>

</div>
</div>
<h3>References</h3>
<div id="refs" class="references csl-bib-body hanging-indent" line-spacing="2">
<div id="ref-aburahmaSocietyVascularSurgery2022" class="csl-entry">
1. AbuRahma, A. F., Avgerinos, E. D., Chang, R. W., Darling, R. C., Duncan, A. A., Forbes, T. L., Malas, M. B., Murad, M. H., Perler, B. A., Powell, R. J., Rockman, C. B., &amp; Zhou, W. (2022). Society for <span>Vascular Surgery</span> clinical practice guidelines for management of extracranial cerebrovascular disease. <em>Journal of Vascular Surgery</em>, <em>75</em>(1), 4S–22S. <a href="https://doi.org/10.1016/j.jvs.2021.04.073">https://doi.org/10.1016/j.jvs.2021.04.073</a>
</div>
<div id="ref-naylorWhyManagementAsymptomatic2015" class="csl-entry">
2. Naylor, A. R. (2015). Why is the management of asymptomatic carotid disease so controversial? <em>The Surgeon</em>, <em>13</em>(1), 34–43. <a href="https://doi.org/10.1016/j.surge.2014.08.004">https://doi.org/10.1016/j.surge.2014.08.004</a>
</div>
<div id="ref-bulbuliaAsymptomaticCarotidSurgery2017" class="csl-entry">
3. Bulbulia, R., &amp; Halliday, A. (2017). The <span>Asymptomatic Carotid Surgery Trial-2</span> (<span>ACST-2</span>): An ongoing randomised controlled trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke. <em>Health Technology Assessment</em>, <em>21</em>(57), 1–40. <a href="https://doi.org/10.3310/hta21570">https://doi.org/10.3310/hta21570</a>
</div>
<div id="ref-rosenfieldRandomizedTrialStent2016" class="csl-entry">
5. Rosenfield, K., Matsumura, J. S., Chaturvedi, S., Riles, T., Ansel, G. M., Metzger, D. C., Wechsler, L., Jaff, M. R., &amp; Gray, W. (2016). Randomized <span>Trial</span> of <span>Stent</span> versus <span>Surgery</span> for <span>Asymptomatic Carotid Stenosis</span>. <em>New England Journal of Medicine</em>, <em>374</em>(11), 1011–1020. <a href="https://doi.org/10.1056/NEJMoa1515706">https://doi.org/10.1056/NEJMoa1515706</a>
</div>
<div id="ref-karamHighDoseAtorvastatinStroke2008" class="csl-entry">
6. Karam, J. G., Loney-Hutchinson, L., &amp; McFarlane, S. I. (2008). High-<span>Dose Atorvastatin After Stroke</span> or <span>Transient Ischemic Attack</span>: <span>The Stroke Prevention</span> by <span>Aggressive Reduction</span> in <span>Cholesterol Levels</span> (<span>SPARCL</span>) <span>Investigators</span>. <em>Journal of the CardioMetabolic Syndrome</em>, <em>3</em>(1), 68–69. <a href="https://doi.org/10.1111/j.1559-4572.2008.07967.x">https://doi.org/10.1111/j.1559-4572.2008.07967.x</a>
</div>
<div id="ref-rothwellEndarterectomySymptomaticCarotid2004" class="csl-entry">
7. Rothwell, P., Eliasziw, M., Gutnikov, S., Warlow, C., &amp; Barnett, H. (2004). Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. <em>The Lancet</em>, <em>363</em>(9413), 915–924. <a href="https://doi.org/10.1016/S0140-6736(04)15785-1">https://doi.org/10.1016/S0140-6736(04)15785-1</a>
</div>
<div id="ref-meershoekTimingCarotidIntervention2018" class="csl-entry">
8. Meershoek, A. J. A., &amp; de Borst, G. J. (2018). Timing of carotid intervention. <em>The British Journal of Surgery</em>, <em>105</em>(10), 1231–1233. <a href="https://doi.org/10.1002/bjs.10950">https://doi.org/10.1002/bjs.10950</a>
</div>
<div id="ref-rantnerEarlyEndarterectomyCarries2017" class="csl-entry">
9. Rantner, B., Kollerits, B., Roubin, G. S., Ringleb, P. A., Jansen, O., Howard, G., Hendrikse, J., Halliday, A., Gregson, J., Eckstein, H.-H., Calvet, D., Bulbulia, R., Bonati, L. H., Becquemin, J.-P., Algra, A., Brown, M. M., Mas, J.-L., Brott, T. G., &amp; Fraedrich, G. (2017). Early <span>Endarterectomy Carries</span> a <span>Lower Procedural Risk Than Early Stenting</span> in <span>Patients With Symptomatic Stenosis</span> of the <span>Internal Carotid Artery</span>. <em>Stroke</em>, <em>48</em>, 1580–1587. <a href="https://doi.org/10.1161/STROKEAHA.116.016233">https://doi.org/10.1161/STROKEAHA.116.016233</a>
</div>
<div id="ref-powers2018GuidelinesEarly2018" class="csl-entry">
10. Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., Jauch, E. C., Kidwell, C. S., Leslie-Mazwi, T. M., Ovbiagele, B., Scott, P. A., Sheth, K. N., Southerland, A. M., Summers, D. V., &amp; Tirschwell, D. L. (2018). 2018 <span>Guidelines</span> for the <span>Early Management</span> of <span>Patients With Acute Ischemic Stroke</span>: <span>A Guideline</span> for <span>Healthcare Professionals From</span> the <span>American Heart Association</span>/<span>American Stroke Association</span>. <em>Stroke</em>, <em>49</em>(3). <a href="https://doi.org/10.1161/STR.0000000000000158">https://doi.org/10.1161/STR.0000000000000158</a>
</div>
<div id="ref-klarinPerioperativeLongtermImpact2016" class="csl-entry">
11. Klarin, D., Lancaster, R. T., Ergul, E., Bertges, D., Goodney, P., Schermerhorn, M. L., Cambria, R. P., &amp; Patel, V. I. (2016). Perioperative and long-term impact of chronic kidney disease on carotid artery interventions. <em>Journal of Vascular Surgery</em>, <em>64</em>(5), 1295–1302. <a href="https://doi.org/10.1016/j.jvs.2016.04.038">https://doi.org/10.1016/j.jvs.2016.04.038</a>
</div>
<div id="ref-giannopoulosRevascularizationRadiationinducedCarotid2018" class="csl-entry">
12. Giannopoulos, S., Texakalidis, P., Jonnalagadda, A. K., Karasavvidis, T., Giannopoulos, S., &amp; Kokkinidis, D. G. (2018). Revascularization of radiation-induced carotid artery stenosis with carotid endarterectomy vs. Carotid artery stenting: <span>A</span> systematic review and meta-analysis. <em>Cardiovascular Revascularization Medicine</em>, <em>19</em>(5), 638–644. <a href="https://doi.org/10.1016/j.carrev.2018.01.014">https://doi.org/10.1016/j.carrev.2018.01.014</a>
</div>
<div id="ref-chungPercutaneousInterventionCarotid2016a" class="csl-entry">
13. Chung, J., Valentine, W., Sharath, S. E., Pathak, A., Barshes, N. R., Pisimisis, G., Kougias, P., &amp; Mills, J. L. (2016). Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management. <em>Journal of Vascular Surgery</em>, <em>64</em>(5), 1286–1294.e1. <a href="https://doi.org/10.1016/j.jvs.2016.05.086">https://doi.org/10.1016/j.jvs.2016.05.086</a>
</div>
<div id="ref-limanetoPathophysiologyDiagnosisVertebrobasilar2017" class="csl-entry">
14. Lima Neto, A. C., Bittar, R., Gattas, G. S., Bor-Seng-Shu, E., Oliveira, M. de L., Monsanto, R. da C., &amp; Bittar, L. F. (2017). Pathophysiology and <span>Diagnosis</span> of <span>Vertebrobasilar Insufficiency</span>: <span>A Review</span> of the <span>Literature</span>. <em>International Archives of Otorhinolaryngology</em>, <em>21</em>(3), 302–307. <a href="https://doi.org/10.1055/s-0036-1593448">https://doi.org/10.1055/s-0036-1593448</a>
</div>
<div id="ref-cohenSinglecenterExperienceEndovascular2012" class="csl-entry">
15. Cohen, J. E., Gomori, J. M., Itshayek, E., Spektor, S., Shoshan, Y., Rosenthal, G., &amp; Moscovici, S. (2012). Single-center experience on endovascular reconstruction of traumatic internal carotid artery dissections: <em>The Journal of Trauma and Acute Care Surgery</em>, <em>72</em>(1), 216–221. <a href="https://doi.org/10.1097/TA.0b013e31823f630a">https://doi.org/10.1097/TA.0b013e31823f630a</a>
</div>
<div id="ref-phamEndovascularStentingExtracranial2011" class="csl-entry">
17. Pham, M. H., Rahme, R. J., Arnaout, O., Hurley, M. C., Bernstein, R. A., Batjer, H. H., &amp; Bendok, B. R. (2011). Endovascular <span>Stenting</span> of <span>Extracranial Carotid</span> and <span>Vertebral Artery Dissections</span>: <span>A Systematic Review</span> of the <span>Literature</span>. <em>Neurosurgery</em>, <em>68</em>(4), 856–866. <a href="https://doi.org/10.1227/NEU.0b013e318209ce03">https://doi.org/10.1227/NEU.0b013e318209ce03</a>
</div>
<div id="ref-naylorSystematicReviewOutcomes2003" class="csl-entry">
18. Naylor, A. R., Cuffe, R. L., Rothwell, P. M., &amp; Bell, P. R. F. (2003). A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass. <em>European Journal of Vascular and Endovascular Surgery</em>, <em>25</em>(5), 380–389. <a href="https://doi.org/10.1053/ejvs.2002.1895">https://doi.org/10.1053/ejvs.2002.1895</a>
</div>
<div id="ref-northamericansymptomaticcarotidendarterectomytrialcollaboratorsBeneficialEffectCarotid1991" class="csl-entry">
19. North American Symptomatic Carotid Endarterectomy Trial Collaborators. (1991). Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. <em>New England Journal of Medicine</em>, <em>325</em>(7), 445–453. <a href="https://doi.org/10.1056/NEJM199108153250701">https://doi.org/10.1056/NEJM199108153250701</a>
</div>
<div id="ref-brottLongTermResultsStenting2016b" class="csl-entry">
20. Brott, T. G., Howard, G., Roubin, G. S., Meschia, J. F., Mackey, A., Brooks, W., Moore, W. S., Hill, M. D., Mantese, V. A., Clark, W. M., Timaran, C. H., Heck, D., Leimgruber, P. P., Sheffet, A. J., Howard, V. J., Chaturvedi, S., Lal, B. K., Voeks, J. H., &amp; Hobson, R. W. (2016). Long-<span>Term Results</span> of <span>Stenting</span> versus <span>Endarterectomy</span> for <span>Carotid-Artery Stenosis</span>. <em>The New England Journal of Medicine</em>, <em>374</em>(11), 1021–1031. <a href="https://doi.org/10.1056/NEJMoa1505215">https://doi.org/10.1056/NEJMoa1505215</a>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="index.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="upper-extremity-and-thoracic-outlet.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": false,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": false,
"email": true
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/adam-mdmph/VS-Board-Review/blob/main/01-cerebrovascular.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["_main.pdf"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true
},
"info": false
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
